Coagulation analyzer and reagents

Ended Definitive Contract Awarded Last action

Contract number
HT940826CE005
Awardee
Awarding agency
Obligated
$9,049

Award facts

Contract value 3% obligated
  • $9,049.26 Current, with exercised options
  • $271,477.80 Potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Set-aside
No set-aside
Competition
Competed under SAP · 4 offers Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Bedford, MA 01730, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00002 · Coagulation analyzer and reagents (COST-per-TEST) -$9,049
Other Administrative Action P00001 $18,099
Original award $0

About this award

The Defense Health Agency awarded a definitive firm-fixed-price contract with a ceiling value of $271,477.80 to Werfen USA LLC for coagulation analyzers and reagents on April 1, 2026. No set-aside was used, and the awardee competes without small business set-aside eligibility. The award covers coagulation analyzers and reagents, with one line priced on a cost-per-test basis. Performance is at Bedford, Massachusetts, 01730, running from the April 1, 2026 award date through an ultimate completion date of July 31, 2031.

Quick answers

Who was awarded contract HT940826CE005?

HT940826CE005 was awarded to Werfen USA LLC by Defense Health Agency (Department of Defense) on April 1, 2026.

How much is contract HT940826CE005 worth?

The government has obligated $9,049 on HT940826CE005. Its potential value, with all options, is $271,478.

Was contract HT940826CE005 competed?

The extent of competition for HT940826CE005 was competed under sap. The government received 4 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award